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Hypertension is a chronic disease that affects most people. Almost every people have certain 
specific factors that can cause this disease to increase. One of which is inadequate physical activity so 
that cholesterol levels remain and tend to get higher, which is a risk factor for heart and blood vessel 
disorders. Patients with this disease and having dyslipidemia complications must treat with appropriate 
therapy until reaching success. The patient's adherence determines the success of the treatment. 
Therefore the purpose of this research is to assess the relationship. Its objects were hypertensive 
patients at the Government Hospital in Yogyakarta. The specialty of the hypertensive patient is having 
dyslipidemia complications. The study uses non-experimental with a cross-sectional study. The sample 
was selected based on the purposive sampling technique in December 2018-February 2019. The 
measurement of therapy adherence used MARS questionnaire and the achievement of therapy targets 
through secondary data on patient blood pressure. Chi-square test was chosen to determine the 
relationship between 2 variables, which are therapy adherence and achieving blood pressure targets. 
The sample in this study were 47 respondents, of which 53.2% of the patients were <60 years old, in 
which 51.1% of them were female. The results showed that patients who were adherent to therapy 
were 25.5%, and those who were not were 74.5%. The results of achieving the blood pressure target 
are known to be 68.1%. The data analysis results showed that the one-way hypothesis in Fisher's test 
obtaining p-value = 0.171 (p> 0.05) was no relationship between adherence and target achievement. 
Therefore the results of this study concluded that there is no relationship between drug therapy 
adherence and blood pressure targets achievement. 
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Hypertension is a disease that affects many people in the world. The disease presents an increase 
of more than 140 mmHg at systolic blood pressure and more than 90 mmHg at diastolic (Weber et al., 
2014). The prevalence of hypertension in Indonesia occurs at age> 18 years as much as 25.8% 
(Kesehatan, 2013). In Yogyakarta, most of this disease is 26.7% (Anonim, 2015), and is the second of 
the ten most common conditions in Bantul district (Dinkes, 2014). 
The increase of blood pressure causes the heart to work faster, and blood does not flow properly, 
so there is a possibility that there will be a decrease in the function of several organs in the body. The 
factors causing this kind of occurrence in each individual can be so varied that it is not easy to 
determine. Some of the most common causes are eating high salted foods, energy-dense foods, fatty 
foods, and a lack of fruit and vegetables. These all can increase the risk of increased blood pressure 
and cardiovascular disease (Ozemek et al., 2018) . World health organization (Day, 2013) estimates 
that high cholesterol levels (hypercholesterolemia) can lead to stroke (20%) and heart problems (> 
50%). And to prevent this occurrence, drug therapy must be successful. 
The patient's adherence to taking the drug influencing the therapy's success, so that blood 
pressure targets achieved and prevent disease complications. Patients with hypertension who do not 
adhere to taking medication according to the rules of use that have been conveyed by health workers 
cause uncontrolled blood pressure and lead to death (Krousel-Wood et al., 2009). Therefore it is 
necessary to do findings in drug therapy adherence and the achievement of blood pressure targets in 
hypertensive patients with dyslipidemia complications at the Government Hospital in Yogyakarta. 
  
MATERIALS AND METHOD  
The non-experimental findings with a cross-sectional study were chosen. Its primary data is 
MARS questionnaire to determine patient adherence to drug therapy, and its secondary data from 
medical records is blood pressure form to assess the achievement of blood pressure targets. The study 
samples were hypertensive patients with dyslipidemia complications having the inclusion or exclusion 
criteria and was undergoing outpatient care at the Government Hospital in Yogyakarta. The inclusion 
criteria were male or female patients, aged ≥18 years, with antihypertensive therapy for at least three 
months. The exclusion criteria were pregnant women with pre-eclampsia, kidney and liver disorders, 
incomplete medical record data, and questionnaires.  
The initial findings procedure was by applying for a finding permit and obtaining ethical 
approval number 011805083 from the Findings Ethics Committee of Ahmad Dahlan University. The 
selection of respondents is based on diagnosis by doctors according to inclusion and exclusion criteria. 
The respondents have explained the study to be carried out and were asked for approval by filling out 
the consent form. They must answer MARS questionnaire to measure adherence in taking drugs after 
the last three months of consumption. The next step was checking the questionnaire results and 
collecting blood pressure data as much as 1x measurement after 3 months of taking the drug through 
medical record data. Univariate analysis was used to determine the percentage of respondent 
characteristics, including age, gender, education level, occupation, habits (exercise, diet, smoking, 
coffee and alcohol consumption), disease complications, medications received by patients, adherence, 
and blood pressure. Bivariate analysis using Chi-square was used to determine the relationship 
between 2 variables: therapy adherence and achievement of blood pressure targets (significance value 
p <0.05). 
 
RESULT AND DISCUSSION  
Patient characteristics data 
The hypertensive patients' characteristics with dyslipidemia complications in Government 
Hospital in Yogyakarta are presented in Table 1. The results showed that patients aged <60 years were 
53.2%. (Kishore et al., 2016)  says that the potential for hypertension will be more significant at the 
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age of over 35 years (21.8%) with an odds ratio of 3.60 (range ratio 2.11-6.15) and p-value = 0.01. It 
means that people over 35 years old are more at risk of developing hypertension.  
 
Table 1. Chi-square analysis on the relationship between patient characteristics and therapy adherence, 
and chi-square analysis on the relationship between characteristics and blood pressure targets 
achievement of hypertensive patients with dyslipidemia complications at the Government 
Hospital in Yogyakarta in the period December 2018-February 2109 
Patient characteristics  Chi-square  Analysis (p-value) 











< 60 years 






































Did not complete basic education 












Exercise        :  Yes 
              No 
Diet               :  Yes 
             No 
Habit             :  Good 



























Types of complications 
Dyslipidemia/CAD+DM 











Note: CAD= coronary artery disease, DM= Diabetes Mellitus 
*significance <0.05 means that there is a significant association between patient characteristics based on 
lifestyle and drug therapy adherence 
 
The research was dominated by women (51,1%). Women usually get high blood pressure after 
menopause. Findings on this have been conducted on thousands of women in America. The results 
showed that higher cholesterol levels in middle-aged women were a potent cause of hypertension. In 
contrast, women with high HDL were found to have a decreased risk of hypertension slightly (Nikolov 
et al., 2015) . The results showed that the majority of patients were workers (83.0%). Low physical 
activity in office workers or people who sit more than 5 hours a day, working with relying on 
automatic machines, are more at risk of suffering hypertension (Bosu, 2017). The findings data shows 
that most of the patients' latest education has graduated from primary education so they may better 
understand drug use instructions to improve therapy adherence and achieve blood pressure targets. 
The results showed that the lifestyle of patients who did physical activity/sports was 68.1%. 
Physical activity or sports are part of the risk of hypertension (Hardati and Ahmad, 2013). The results 
also showed that patients who did a diet were 66.0%. A finding in Africa showed that excess fat 
consumed is the cause of hypertension (Ramirez et al., 2010). So the findings result is divided into two 
categories of habits, which are good and less. 
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Good habits are defined when the patient does not consume alcohol, tea, coffee, or smoke. Bad 
habits are determined when the patient drinks alcohol, tea, coffee, and smokes, or just one of these. 
The results showed that the patients had good habits as much as 61.7%. Drinking coffee can increase 
blood pressure briefly but then return to normal. There is no significant relationship between coffee 
drinking habits and increased blood pressure in adults (Bistara  and  Kartini, 2018). 
The findings showed that most complications suffered by patients were hypertension with 
dyslipidemia complications (CAD) and Diabetes Mellitus (74.5%). They were also had other diseases 
such as OA, IHD, asthma, cholelithiasis, CHF, BPH, HHD, hyperuricemia, LBP, GERD, and 
cephalgia. Based on patients' characteristics toward therapy adherence, it concluded that there was no 
significant relationship (p> 0.05) on each aspect unless the factors of lifestyle in the form of customs 
patients do not consume alcohol, tea, coffee, or smoke obtained p-value = 0.038. The relationship 




The results of the study on antihypertensive and antidyslipidemic drugs obtained by patients are 
presented in Table 2. 
 
 Table 2. Antihypertensive and antidyslipidemic drugs received by hypertensive patients with 






(%) Statin Fibrate 
Combination 
statin+fibrat 
CCB (amlodipine) 5 (10.7%) 3 (6.4%) 1 (2.1%) 
47 
(100) 
ARB (irbesartan, candesartan) 4 (8.5%) 2 (4.3%) 2 (4.3%) 
Beta Bloker (bisoprolol) 0 (0%) 1 (2.1%) 0 (0%) 
ARB+Beta Bloker (valsartan/candesartan+ bisoprolol) 1 (2.1%) 4 (8.5%) 0 (0%) 
ARB+CCB (irbesartan/candesartan/ valsartan+ amlodipine) 8 (17.0%) 5 (10.7%) 5 (10.7%) 
ARB+Diuretic (candesartan+ furosemide) 0 (0%) 1 (2.1%) 0 (0%) 
ARB+ARB (valsartan+candesartan) 0 (0%) 1 (2.1%) 0 (0%) 
ARB+CCB+ Beta Bloker  ( valsartan+ amlodipine+ 
bisoprolol) 
0 (0%) 1 (2.1%) 0 (0%) 
ARB+Diuretic+Beta Bloker  
(candesartan+furosemide+ bisoprolol) 
1 (2.1%) 0 (0%) 0 (0%) 
ARB+ARB+ Beta Bloker (candesartan+ irbesartan+ 
bisoprolol) 
1 (2.1%) 0 (0%) 0 (0%) 
ARB+CCB+ Diuretic (candesartan,amlodipine, furosemide) 0 (0%) 1 (2.1%) 0 (0%) 
Note: CCB: Calcium Channel Blocker, ARB: Angiotensin Receptor Blocker, 
 
 
Data on antihypertensive drug therapy were accepted from the findings. Those are single 
therapy, a combination of two drugs, and an assortment of three drugs from various antihypertensive 
groups. This available antihypertensive therapy is used in patients with stage I hypertension, and two 
or three combination therapy is used in patients with stage II hypertension. (Bakris et al., 2003) 
Antihypertensive and antidyslipidemic drugs, which were often used by the patients, were CCB 
combination with ARB and statin (17%). (Last et al., 2017)  suggest that statin therapy should be 
prescribed for secondary prevention in patients with known ASCVD (atherosclerotic cardiovascular 
disease), unless contraindicated. The more significant amount of drugs used by the patient may affect 
adherence in taking drugs. 
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Therapeutic adherence in the research was measured based on the results of filling out MARS 
questionnaire. Measurement of patient adherence to therapy was carried out once after consuming the 
doctor's drug for three months. To measure the consumption of antihypertensive and anti-cholesterol 
drugs, they were given two MARS questionnaires. Patients are said to be adherent in taking drugs if 
the total score from the measurement of antihypertensive and anti-cholesterol therapy is known to have 
each score = 25. It is said to be non-adherent if the score of the two measures or one of them is a score 
<25. Data based on patient therapy are presented in Table 3. 
 
Table 3. Therapy adherence of hypertensive patients with dyslipidemia complications at Government 
Hospital in Yogyakarta for period December 2018-February 2019  
Therapy 
Adherence 





Adherent 12 25,5 
0,000* 
Non-adherent 35 74,5 
*p-value <0.05 means that there are significant differences in patients who are adherent and non-adherent 
 
The results obtained 12 patients (25.5%) who adhere to drug therapy, antihypertensive, and anti-
cholesterol drugs. The finding's results were following (Hazwan and Pinatih, 2017), where the level of 
adherence to hypertension drugs is relatively high for about 30%. Adherence to drug therapy affects 
the patient's blood pressure because it can be controlled. Patients who reach their target blood pressure 
are considered to have high levels of adherence. From Maan Withney's difference test, groups of 
patients who adhered and did not adhere to taking the drug toward the score obtained a value of p = 
0.000. It is showed that there is a significant difference in scores between patients who are adherent 
and non-adherent in taking the drug. Uncontrolled hypertension for a long time can lead to heart 
attacks, enlarged hearts, and heart failure. Hypertension causes the blood vessels' muscle wall to 
weaken, thus developing a bulge (aneurysm), which is thought to be a blockage and rupture of the 
blood vessel. The high pressure in the blood vessels can leak or bleed, resulting in a stroke. 
Hypertension is also known to give rise to kidney failure, vision problems, and cognitive impairment 
(WHO, 2015). 
In Table 4, some patients stated that they forgot to take drugs. No one reminds them about the 
time, the amount of drug that must be consumed, and because of being busy. Inadvertently forgetting 
to take a drug is also because the patient feels that their body condition has improved. 
 
Table 4. Duration of taking hypertension drugs on the MARS questionnaire in hypertensive patients with 
dyslipidemia complications at Government Hospital in Yogyakarta in the period December 2018-
February 2019 
Questions 
Selection of questions 
Total 
Always Often Occasionally Rarely Never 
Fail to take drug 0 (0%) 4 (8,5%) 11 (23,4%) 16 (34,0%) 16 (34,0%) 
47 
(100%) 
Change the dosage 0(0%) 0 (0%) 3 (6,4%) 3 (6,4%) 41 (87,2%) 
Stop to take drug 0 (0%) 1 (2,1%) 10 (21,3%) 11 (23,4%) 25 (53,2%) 
Decided not to adhere 
the dosage 
0 (0%) 2 (4,3%) 3 (6,4%) 4 (8,5%) 38 (80,9%) 
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Achievement of therapeutic targets 
 
Table 5. Achievement of therapy targets in hypertensive patients with dyslipidemia complications at the 







Achieved  32 68,1 
0,000 Not Achieved 15 31,9 
* p-value <0.05 means that there is a significant difference between patients who have achieved and not 
achieved blood pressure target 
 
The results in Table 5. showed that 68.1% of patients suffering from hypertension with 
dyslipidemia complications at the Government Hospital in Yogyakarta achieved the blood pressure 
target as the therapy, according to JNC 8. The findings showed that the blood pressure targets 
achievement of hypertensive patients without diabetes complications at age <60 years old was <140/90 
mmHg, at age ≥60, years old was <150/90 mmHg, and whose diabetes complications <140/90 mmHg 
(Dennison-himmelfarb, 2014). The blood pressure of patients with an exact lower limit of 140/90 
mmHg or 150/90 mmHg is included in the unachieved category. The factor that causes blood pressure 
target to be unachieved is non-adherent with the drug therapy. The Mann Withney's different test 
results showed the value of p = 0.000, so this indicates a significant difference in blood pressure 
results between patients who achieved the target and was unachieved. 
 
Chi-square analysis: the relationship between therapy adherent towards blood pressure target 
achievement 
A Chi-square test was used to analyze the relationship between therapeutic adherence and the 
result of blood pressure target achievement. The Findings selected Fisher's trial because the 2x2 table 
did not meet the Chi-square requirements, in which more than 20% of cells had a smaller expected 
than 5 (Dahlan, 2014). The one-way hypothesis obtained a significance value of p = 0.171, which 
means that the required conditions were unfulfilled, so there was no relationship between patient 
adherence to the blood pressure target. The Odds Ratio value (CI 95%) was 2.955 (0.559 - 15.630). 
The findings showed that therapeutic adherent has a risk of 2,955 times to affect blood pressure 
compared with non-adherents. The patient's blood pressure probably influences it at the target limit, 
categorized as unachieved by the findings. Another factor that may have influenced the results could 
also be because the patient was classified as adhering if all five questions were met with a total score 
of 25, so it is necessary to include a limit value in future findings. Chi-square test analysis of the 
relationship between therapy adherence with the results of blood pressure target can be seen in Table 
6. 
 
Table 6. Chi-square test analysis of the relationship between therapy adherence with the results of blood 
pressure target in Government Hospital in Yogyakarta for the period December 2018-February 
2019 
Therapy Adherent 





(CI 95%) Achieved Unachieved 




(0.559 - 15.630) Not Adhere 22 (46.8%) 13 (27.7%) 
  Note: p-value (sig> 0.05) means no relationship between therapy adherence and target achievement. 
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The results showed that most of the respondents had diabetes mellitus (74.5%) as a comorbid 
disease. The chi-square statistical test results on the relationship between patients' characteristics 
related to comorbid and therapeutic adherence obtained a p-value of 0.481 (> 0.05). The findings 
conclude that there is no comorbid influence on therapy adherence. The chi-square statistical test 
results for the relationship between patients' characteristics related to comorbid and the achievement of 
blood pressure targets obtained a p-value of 0.281 (> 0.05). Table 1 shows that comorbid does not 
affect blood pressure targets achievement as presented. The findings were different from (Cahyani, 
2018). It concluded a significant relationship between adherence to taking antihypertensive drugs and 
blood pressure (p-value = 0.005), with hypertensive patients with diabetes mellitus complications 
considering that this patient has a high adherence level. Comorbidities may directly influence the 
complexity of the treatment, the amount of drug consumed, the cost, and the patient's motivation. In a 
study conducted, other factors, such as exercise, diet, tea consumption, coffee, and alcohol, also affect 
not achieving therapeutic targets. The findings lack the data collection that was carried out once when 
the patient had taken the drug for three months, so that the progress in achieving the target each month 
was not known. Also, the sample size was limited, only using hypertensive patients with dyslipidemia 
and other complications. 
 
CONCLUSION  
The research concluded that 25.5% of patients adhere to take antihypertensive and 
antidyslipidemic consumption, and 68.1% of patients achieved their blood pressure. There is no 
relationship between drug therapy adherence to the results of blood pressure targets achievement in 
hypertensive patients with dyslipidemia complications at the Government Hospital in Yogyakarta at 
the period December 2018-February 2019 (p=0.171). 
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